Surgical Treatment Provides Better Long-Term Survival for NSCLC
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, May 22, 2023 -- Long-term survival favors surgical management over stereotactic body radiotherapy (SBRT) for treatment of early-stage, non-small cell lung cancer (NSCLC), according to a study presented at the annual meeting of the American Association for Thoracic Surgery, held from May 6 to 9 in Los Angeles.
Brooks Udelsman, M.D., from Yale-New Haven Hospital in Connecticut, and colleagues evaluated trends in the utilization of SBRT and the long-term survival for SBRT versus surgery in otherwise healthy patients with early-stage NSCLC. The analysis included 24,729 patients (80.7 percent) who underwent surgery and 5,929 (19.3 percent) treated with SBRT.
The researchers found that between 2012 and 2018, the proportion of patients receiving SBRT increased from 15.9 to 26.0 percent. Increasing age (odds ratio [OR], 1.09) and squamous histology (OR, 1.25) were associated with receiving SBRT. Among patients undergoing surgical resection, the 30-day and 90-day mortality rates were higher versus SBRT (1.7 versus 0.3 percent and 2.8 versus 1.7 percent, respectively). However, among surgically managed patients, the unadjusted five-year survival rate was higher (75.8 versus 40.5 percent). Using data from propensity-matched patients, survival favored SBRT for the first several months but separated after one year and significantly favored surgical management by year 2.
"Among patients that are eligible for either treatment, the long-term survival appears to favor surgical management over SBRT, particularly for patients with a health-related life expectancy [exceeding] two years," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2023
Read this next
GLP1 Receptor Agonists Do Not Up Risk for Complications After Emergency Surgery
THURSDAY, April 25, 2024 -- The risk for postoperative respiratory complications is similar among patients undergoing emergency surgery regardless of preoperative glucagon-like...
Wearable Technology During Surgery Provides Neurosurgeons With Postural Info
WEDNESDAY, April 24, 2024 -- Wearable technology is feasible to assess postural ergonomics and provide objective biofeedback to neurosurgeons, according to a pilot study published...
Knee Osteoarthritis Symptoms Common After ACL Reconstruction
TUESDAY, April 23, 2024 -- Nearly one-quarter of patients show persistent early knee osteoarthritis (OA) symptoms six to 12 months after anterior cruciate ligament reconstruction...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.